Novel beta-lactamase from Branhamella catarrhalis

Area of Science:

• Microbiology
• Biochemistry
• Molecular Biology

Background:

• Branhamella catarrhalis is a common respiratory pathogen.
• Antibiotic resistance, particularly to beta-lactam antibiotics like penicillin and ampicillin, is a growing concern.
• Beta-lactamase enzymes are a primary mechanism of resistance to these drugs.

Purpose of the Study:

• To investigate the antibiotic resistance profile of a Branhamella catarrhalis strain isolated from sputum.
• To characterize the beta-lactamase enzyme produced by this resistant strain.
• To determine if the identified beta-lactamase represents a novel enzyme.

Main Methods:

• Isolation and identification of Branhamella catarrhalis from patient sputum.
• Antibiotic susceptibility testing against penicillin and ampicillin.
• Biochemical characterization of the produced beta-lactamase, including substrate profile and isoelectric point determination.
• Analysis of the genetic determinant location for the beta-lactamase.

Main Results:

• The isolated Branhamella catarrhalis strain exhibited resistance to penicillin and ampicillin.
• A beta-lactamase enzyme was detected in the resistant strain.
• Characterization revealed unique properties (substrate profile, isoelectric point, genetic determinant location) suggesting novelty.

Conclusions:

• Branhamella catarrhalis can possess novel beta-lactamase enzymes conferring significant antibiotic resistance.
• The discovery of this novel enzyme necessitates further research into its structure, function, and prevalence.
• Understanding novel resistance mechanisms is crucial for developing effective therapeutic strategies against Branhamella catarrhalis infections.